Detection of bacterial antigens in body fluids with the Wellcogen Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis (ACYW135) latex agglutination tests.

AUTOR(ES)

Ingram, D L

RESUMO

The Wellcogen Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis (ACYW135) latex agglutination tests (Wellcome Diagnostics, Dartford, England) were evaluated as methods to detect bacterial antigens in cerebrospinal fluid (CSF), urine, and serum from patients with meningitis or sepsis. Antigen was detected in 92% of CSFs from H. influenzae b, 100% of CSFs from N. meningitidis groups A and Y, 36% of CSFs from N. meningitidis group C, and 69% of CSFs from pneumococcal meningitidis patients. Serum samples presented a problem, with a few false-positive or possible cross-reactions. The Wellcogen latex agglutination tests were more sensitive than the Bactogen (H. influenzae type b) latex agglutination test and the Phadebact (S. pneumoniae) coagglutination test.

Documentos Relacionados

• Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis.
• Use of the directigen latex agglutination test for detection of Haemophilus influenzae, Streptococcus pneumoniae, and Neisseria meningitidis antigens in cerebrospinal fluid from meningitis patients.
• Commercial latex agglutination tests for detection of Haemophilus influenzae type b and Streptococcus pneumoniae antigens in patients with bacteremic pneumonia.
• Detection of Neisseria meningitidis group A, Haemophilus influenzae type b, and Streptococcus pneumoniae antigens in cerebrospinal fluid specimens by antigen capture enzyme-linked immunosorbent assays.
• Improved detection of bacterial antigens by latex agglutination after rapid extraction from body fluids.